Market Currents
A U.S. District Judge has accepted a guilty plea from Amgen (AMGN) and approved a $762M...
-
Thursday, December 27, 2012, 4:44 PM ETA U.S. District Judge has accepted a guilty plea from Amgen (AMGN) and approved a $762M settlement to resolve criminal and civil liability arising from its illegal sale and misbranded promotion of Aranesp, which caused false claims to be submitted to Medicare, Medicaid and other government insurance programs. The settlement is the largest ever of its kind to involve a biotechnology firm.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
